BONE BIOLOGICS CORP - COM NEW (BBLG)

CUSIP: 098070303

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM NEW
Total 13F shares
2,263,720
Share change
+2,222,382
Total reported value
$469,676
Price per share
$0.21
Number of holders
12
Value change
+$432,780
Number of buys
12
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 098070303?
CUSIP 098070303 identifies BBLG - BONE BIOLOGICS CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BONE BIOLOGICS CORP - COM NEW (BBLG) as of Q4 2022

As of 31 Dec 2022, BONE BIOLOGICS CORP - COM NEW (BBLG) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,263,720 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, Walleye Capital LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, Warberg Asset Management LLC, HRT FINANCIAL LP, Virtu Financial LLC, UBS Group AG, Cetera Advisor Networks LLC, and Tower Research Capital LLC (TRC). This page lists 12 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.